Tinidazole
As of the edition of 20 October 2026, Tinidazole is a small molecule: marketed, first approved in 1974 (ES).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2004
- Kind
- Small molecule
- Brand name
- Tindamax
- First approved
- 1 September 1974 (ES)
- Approvals on record
- 5 in 3 regions
- Holder of the most recent approval
- MISSION PHARMA; 4 holders in all
- Registered trials
- 18, 1 stopped early
- Disease areas
- Infections; Urinary and reproductive; Pregnancy and women's health; Digestive system; Cancer; Inherited and neonatal
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 4 | 0 | 1 | 0 |
| Phase 2 | 4 | 2 | 1 | 1 |
| Phase 3 | 5 | 4 | 0 | 0 |
| Phase 4 | 5 | 3 | 0 | 0 |
| All trials | 18 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Mission Pharmacal | Acquired holder and Lead sponsor of trials | 2005 to now |